Drug-related cardiotoxicity causes 45% of drug withdrawals. Yet no FDA guidelines or standard preclinical tests, or clinical biomarkers exist. What’s in store for cardiotoxicity testing in drug discovery and development?
Making Commercial Successes out of Life Science Innovations
READ OUR MOST RECENT ARTICLES
This morning I came across Cellzome’s website and on further exploration I think it’s an excellent example of a technology platform company that’s got it right. You don’t see many of these, and I think it serves as a good role model to learn from.
Cellzome’s website is small, simple and a similar website would be inexpensive to develop (around £7K including content). Its simplicity and clarity is what makes it special. No heavy word-ridden content; just clear and simple messages:
Last week I got a call from an old friend and ex-colleague who bemoaned about how the marketing tactics at his very large life science technology company had pretty much reduced to a handle-turning exercise that was no longer working. Open rates on their emails had fallen to an all-time low, social media efforts were “unproven”, leads coming in from phone and website had dropped off.
When you look at a problem like this, it’s tempting to respond by changing the tactics, refreshing the branding and content, and give the marketing campaigns a “reboot”. Try a webinar series, a workshop, …